Topic: Cymbalta

A comparison of television advertisements for Celebrex and Cymbalta focuses on the increasingly dire side effects listed in the disclaimers. The hosts note that Celebrex now explicitly mentions the risk of death, while Cymbalta lists suicidal thoughts and liver failure. They track the annual revenue of both drugs to see if "scarier" ads correlate with higher sales.

A CNN human interest segment about a young percussionist is criticized for transitioning directly into a pharmaceutical advertisement for Cymbalta. The hosts suggest that under Jeff Zucker, news reporters may be encouraged to find their own sponsors or integrate product mentions into their stories. This "freemium" reporter model is discussed as a potential future for struggling news networks.

USA Today reports on a University of Cambridge study suggesting mental health screenings should be part of annual physical exams. The discussion pivots to the dangers of psychiatric drugs like Cymbalta and Chantix, noting reports of blackouts and violent ideation. A preference for traditional opiates like morphine for pain management is expressed due to their more predictable side effects compared to modern psychotropics.

Cymbalta, an FDA-approved drug for chronic musculoskeletal pain, is under scrutiny for its extensive list of side effects, including suicidal thoughts, liver failure, and skin reactions. A listener reported experiencing extreme sadness and a blackout after taking the medication, during which he reportedly spoke about "werewolves and vampires." The drug's transition from an antidepressant to a general pain reliever is noted as a strategic patent move.

An analysis of a highly aggressive Cymbalta advertisement that frames the drug as a tool for "taking action" against chronic pain and depression. The segment highlights the extensive list of potential side effects, including liver failure, suicidal thoughts, and skin reactions, contrasted with the upbeat marketing tone.

A comparison of commercials for Celebrex and Cymbalta reveals a trend of increasingly severe side effect warnings, including the explicit mention of death. Despite the warnings, both drugs generate billions in annual revenue, supporting a theory that "scary" side effects do not deter sales.

The NBC show "Smash" is criticized for allegedly coordinating its dramatic content with pharmaceutical advertisements. A specific instance is cited where a character's depressive episode transitioned directly into a commercial for the antidepressant Cymbalta, using similar musical cues. The segment highlights the extensive list of side effects disclosed in drug advertisements, including "unusual changes in behavior."

An analysis of a television commercial for the antidepressant Cymbalta focuses on the disproportionate length of the side-effect disclaimers compared to the sales pitch. The hosts note the inclusion of subtle audio cues like dog barks and bird chirps intended to influence the viewer's mood. They highlight the irony of an antidepressant warning of increased suicidal thoughts and liver failure.